Today: 24 April 2026
Subscribe
Browse Category

Stock Market 10 December 2025

Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

Tilray Brands shares surged 12.4% to $8.09 on December 9, 2025, after weeks of steep declines and heavy trading volume. The rebound followed news of a Florida bill to allow home cannabis cultivation and renewed speculation over U.S. federal rescheduling. Tilray remains down 65% from its October high and recently completed a 1-for-10 reverse stock split.
10 December 2025
···
1-800-FLOWERS.COM (FLWS) Stock Jumps 30% on AI-Focused CIO Hire: Latest News, Debt Risk and 2026 Forecast

1-800-FLOWERS.COM (FLWS) Stock Jumps 30% on AI-Focused CIO Hire: Latest News, Debt Risk and 2026 Forecast

1-800-FLOWERS.COM shares jumped 32.8% to $4.94 on December 9, 2025, after naming Alexander Zelikovsky as Chief Information Officer to lead AI and digital commerce initiatives. Trading volume surged to 6.3 million shares. The stock remains down about 46% from its 52-week high, with its balance sheet and earnings still under pressure.
10 December 2025
···
Microsoft Stock (MSFT) on December 10, 2025: $23 Billion AI Bet, Analyst Targets and What It Means for Investors

Microsoft Stock (MSFT) on December 10, 2025: $23 Billion AI Bet, Analyst Targets and What It Means for Investors

Microsoft shares traded near $492 midday, valuing the company at $3.85 trillion, after announcing $23 billion in new AI infrastructure spending across India, Canada, and the U.S. The stock sits about 9% below its October record high. Wall Street targets now reach the mid-$600s, but some analysts warn current prices reflect high optimism. Microsoft reported FY 2025 revenue of $281.7 billion and net income of $101.8 billion.
10 December 2025
···
Twenty One Capital (XXI) Stock: NYSE Debut, Bitcoin Treasury Bet and 2026 Outlook

Twenty One Capital (XXI) Stock: NYSE Debut, Bitcoin Treasury Bet and 2026 Outlook

Twenty One Capital (NYSE: XXI) debuted on the NYSE December 9, 2025, after merging with Cantor Equity Partners. Shares fell nearly 20% on the first day, closing at $11.42 despite the company holding over 43,500 Bitcoin. Early pre-market trading on December 10 showed a slight recovery toward $12.10. Jack Mallers leads the company, with Tether, Bitfinex, and SoftBank as major backers.
10 December 2025
··
CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

CVS Health raised its 2025–2026 profit outlook and launched an AI-driven engagement platform at its Investor Day in Hartford, sending shares up 2% to around $78 on December 10. The stock has surged nearly 80% year to date. CVS now expects at least $400 billion in 2025 revenue and adjusted EPS of $6.60–$6.70, above prior guidance. Management projects mid-teens adjusted EPS growth through 2028.
10 December 2025
··
Meta Platforms (META) Stock on December 10, 2025: AI Pivot, EU Rulings and New Price Targets

Meta Platforms (META) Stock on December 10, 2025: AI Pivot, EU Rulings and New Price Targets

Meta Platforms traded at $656–$657 per share Wednesday, down 1.5% from the previous close, with a market cap near $1.85 trillion. Shares remain below late-October highs after a sharp drop following Q3 earnings and a surge in AI spending plans. Meta is cutting Reality Labs’ budget by up to 30% and expects to spend about $72 billion on AI in 2025. The company recently invested $14 billion in Scale AI for a 49% stake.
10 December 2025
····
Pan American Silver Stock (PAAS) Hits 12‑Month High as Silver Breaks $60: What Today’s Rally Means for 2026

Pan American Silver Stock (PAAS) Hits 12‑Month High as Silver Breaks $60: What Today’s Rally Means for 2026

Pan American Silver shares hit a 12-month high of $48.78 on December 10, 2025, after jumping 11% the previous day. The surge follows silver’s move above $60 per ounce and anticipation of a Federal Reserve rate cut. Trading volume topped 17 million shares, with the company’s market cap near $20.4 billion. Strong Q3 cash flow, higher production guidance, and recent acquisitions also supported the rally.
10 December 2025
··
Broadcom (AVGO) Stock Near Record High Ahead of Q4 2025 Earnings: AI Supercycle, Analyst Upgrades and 2030 Forecasts

Broadcom (AVGO) Stock Near Record High Ahead of Q4 2025 Earnings: AI Supercycle, Analyst Upgrades and 2030 Forecasts

Broadcom shares traded at $406 on December 10, 2025, just below the 52-week high of $407.29, valuing the company at $1.92 trillion. The company reports fiscal Q4 earnings on December 11, with analysts expecting revenue near $17.5 billion and adjusted EPS of $1.88, both up sharply year over year. AI semiconductor revenue is projected at $6.2 billion, about a third of total sales.
10 December 2025
····
Nvidia (NVDA) Stock Today: Trump’s H200 Green Light, New Chip-Tracking Tech and Fresh 2026 Price Targets

Nvidia (NVDA) Stock Today: Trump’s H200 Green Light, New Chip-Tracking Tech and Fresh 2026 Price Targets

The U.S. government has approved Nvidia to resume sales of its H200 AI chips to select Chinese customers, requiring the company to share 25% of related revenue with Washington. Nvidia shares traded near $185 midday, down slightly but up nearly 40% year-to-date. The new policy does not cover Nvidia’s most advanced chips, which remain restricted. Beijing is considering its response as analysts raise 2026 forecasts.
10 December 2025
···
Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals (NASDAQ: BDRX) closed at $4.09 on December 9, down 53.5% from the prior session, after wild swings that saw the stock trade between $4.00 and $7.60 intraday. The company is advancing a Phase 3 trial in a rare inherited cancer syndrome and exploring new financing. Its float remains under 670,000 ADSs, fueling extreme volatility. Market cap stands near $5.5 million.
10 December 2025
··
Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax shares surged as much as 20% on December 10, 2025, in Paris trading amid market rumors of a possible takeover bid by Eli Lilly. The stock hit a 52-week high near €126.60, with market value reaching about €9.7 billion. Abivax declined to comment, and no formal offer has been announced. U.S.-listed ADRs also jumped over 11% in pre-market trading.
10 December 2025
····
JPMorgan Chase (JPM) Stock on December 10, 2025: Expense Shock, Dividend Update and Wall Street Forecasts

JPMorgan Chase (JPM) Stock on December 10, 2025: Expense Shock, Dividend Update and Wall Street Forecasts

JPMorgan Chase shares fell nearly 5% on December 9 after executives projected 2026 expenses of about $105 billion, well above Wall Street estimates. The bank reaffirmed its $1.50 quarterly dividend. As of late morning December 10, shares traded near $300.50, recovering from the sharpest one-day drop in eight months. Analysts remain broadly positive on the stock’s long-term outlook.
10 December 2025
··
Newmont Stock Soars on Gold Rally: Latest NEM News, Analyst Forecasts and 2026 Outlook (10 December 2025)

Newmont Stock Soars on Gold Rally: Latest NEM News, Analyst Forecasts and 2026 Outlook (10 December 2025)

Newmont shares rose 5.7% to $94.09 by mid-day on December 10, with trading volume near 8.7 million. The stock is up over 130% year-to-date, fueled by a surge in gold prices and company restructuring. Newmont sits just below its 52-week high of $98.58 reached in October. Analysts cite strong operational progress and increased mainstream investor interest.
10 December 2025
··
Oracle Stock Today: AI Bets, Debt Fears and What to Watch in Q2 FY26 Earnings

Oracle Stock Today: AI Bets, Debt Fears and What to Watch in Q2 FY26 Earnings

Oracle reports fiscal Q2 2026 earnings after market close, with consensus expecting revenue of $16.2 billion, up 15% year over year, and adjusted EPS of $1.64. Shares traded at $221.53 midday, up about a third in 2025. Options markets imply a 10% swing on the results. Wall Street is watching for signs that Oracle’s AI-driven cloud growth can withstand concerns over debt and customer concentration.
10 December 2025
····
Most Active Stocks Today: Nvidia, Tesla, PAVS, American Airlines and More Drive U.S. Market Volume on December 10, 2025

Most Active Stocks Today: Nvidia, Tesla, PAVS, American Airlines and More Drive U.S. Market Volume on December 10, 2025

Nvidia (NVDA) led U.S. trading volume on December 10, 2025, with about 145 million shares exchanged as the stock hovered near $185. Warner Bros. Discovery (WBD) surged after a $108 billion hostile bid from Paramount Skydance. Microcaps like Paranovus (PAVS) and Senti Biosciences (SNTI) posted sharp volume spikes. Wall Street traded cautiously ahead of the Federal Reserve’s final policy decision of the year.
10 December 2025
Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

Dyne Therapeutics shares fell 16.9% to $18.44 after announcing a $300 million stock offering. SLM Corp dropped 15%, Kontoor Brands slid 9.5%, and Waystar Holding lost 8.4%. Major indexes were little changed as investors awaited the Federal Reserve’s interest-rate decision. The U.S. 10-year Treasury yield hovered near 4.19%.
10 December 2025
···········
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision

Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision

A SPAC III Acquisition (ASPC) surged over 100% pre-market Dec. 10, trading between $25 and $31 after sharp gains in after-hours. Enveric Biosciences (ENVB) and Biodexa Pharmaceuticals (BDRX) also posted triple- and double-digit percentage gains. Major U.S. index futures were little changed ahead of the Federal Reserve’s final 2025 rate decision. Speculative micro-caps and SPACs led early trading volatility.
10 December 2025
··········
Google Stock Pre‑Market Today (Dec. 10, 2025): GOOGL, GOOG Price Action and Key Levels to Watch

Google Stock Pre‑Market Today (Dec. 10, 2025): GOOGL, GOOG Price Action and Key Levels to Watch

Alphabet’s GOOGL shares traded around $312.70 pre-market Wednesday, down 1.4% from Tuesday’s $317.08 close, with volume below the monthly average. GOOG was at $315.36, off 0.75%. Both classes remain near 52-week highs after a 72% year-over-year gain. Traders are watching resistance at $316.60 and $318–$320 ahead of a key Federal Reserve decision.
10 December 2025
···
Intel Stock Pre-Market Today (December 10, 2025): EU Fine Cut, AI Deal Buzz and the Key Levels INTC Traders Are Watching

Intel Stock Pre-Market Today (December 10, 2025): EU Fine Cut, AI Deal Buzz and the Key Levels INTC Traders Are Watching

Intel shares traded around $40.75–$40.77 pre-market Wednesday, up slightly from Tuesday’s $40.50 close, with over 1 million shares changing hands before the bell. The move follows heavy news flow, including an EU court ruling and AI M&A headlines, as markets await the Fed’s rate decision. The stock is near the upper third of its 52-week range and has doubled over the past year.
10 December 2025
·
Netflix Stock Pre-Market Today (December 10, 2025): Warner Bros. Bidding War and Antitrust Jitters Keep NFLX on Edge

Netflix Stock Pre-Market Today (December 10, 2025): Warner Bros. Bidding War and Antitrust Jitters Keep NFLX on Edge

Netflix traded around $96.50 in early U.S. pre-market action Wednesday, down slightly from Tuesday’s $96.71 close, after a $82.7 billion deal to acquire Warner Bros. Discovery’s entertainment assets. Shares have fallen about 9–10% over the past week and sit nearly 28% below their 52-week high. Investors remain cautious amid a competing $108.4 billion hostile counter-offer from Paramount Skydance and regulatory scrutiny.
10 December 2025
·····
1 … 1,019 1,020 1,021 1,022 1,023 … 1,385

Stock Market Today

  • Heartland Express Q1 2026 Earnings Beat Revenue Expectations Despite Sales Drop
    April 23, 2026, 7:34 PM EDT. Heartland Express (NASDAQ:HTLD) reported Q1 CY2026 revenue of $176.3 million, surpassing analyst estimates by 2.6% despite a 19.7% year-on-year sales decline. The freight delivery company's adjusted earnings per share (EPS) loss narrowed to $0.06, beating forecasts by 53.1%. Adjusted EBITDA rose 18.5% over projections, reaching $31.86 million, with an operating margin improving to -1.9% from -6.8% year prior. CEO Mike Gerdin highlighted operational improvements amid weather-related challenges and higher fuel costs. The company maintains positive operating cash flow, investing in fleet and infrastructure while reducing acquisition debt. Heartland Express's five-year sales growth remains modest at 3.8% compounded annually, lagging industrials sector standards.

Latest article

Newmont earnings today: Gold miner beats Q1 profit, adds $6 billion buyback but warns on Q2 costs

Newmont earnings today: Gold miner beats Q1 profit, adds $6 billion buyback but warns on Q2 costs

24 April 2026
Newmont reported adjusted first-quarter earnings of $2.90 per share on $7.31 billion in sales, beating estimates as realized gold prices surged to $4,900 an ounce. Attributable gold output fell to 1.30 million ounces from 1.54 million a year earlier. The miner declared a $0.26 dividend and authorized a new $6 billion share buyback. Newmont expects higher costs and lower output in the second quarter.
SAP Q1 Earnings Beat Forecasts as Cloud Revenue Climbs 27% in Constant Currencies, Outlook Holds

SAP Q1 Earnings Beat Forecasts as Cloud Revenue Climbs 27% in Constant Currencies, Outlook Holds

24 April 2026
SAP reported a 17% rise in first-quarter operating profit to 2.74 billion euros and a 19% jump in cloud revenue to 5.96 billion euros, beating forecasts. The company kept its 2026 targets and full-year outlook unchanged. SAP’s U.S. shares reversed losses after the results, climbing nearly 7% in after-hours trading. Management warned cloud revenue growth will slow in the second quarter.
MaxLinear Stock Surges as AI Data-Center Chip Demand Drives Big Q2 Outlook

MaxLinear Stock Surges as AI Data-Center Chip Demand Drives Big Q2 Outlook

24 April 2026
MaxLinear forecast second-quarter revenue of $160 million to $170 million, well above Wall Street’s estimate of $137.1 million. First-quarter revenue rose 43% to $137.2 million, driven by demand for optical products in AI data centers. Shares surged over 23% to $42.47 in after-hours trading. Infrastructure revenue jumped 136% from a year earlier, becoming the company’s largest segment.
Go toTop